Top Clinical Trials companies in Canada by Shareholders' Equity
Canada
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 1.15 B
|
Dec. 31, 2023 | USD 3.17 | -1.86% |
|
Canada |
|
| 2 |
USD 927.92 M
|
Dec. 31, 2023 | USD 39.98 | -1.21% |
|
Canada |
|
| 3 |
USD 563.51 M
|
Dec. 31, 2023 | USD 4.00 | 3.39% |
|
Canada |
|
| 4 |
USD 464.81 M
|
Dec. 31, 2023 | USD 14.60 | -0.95% |
|
Canada |
|
| 5 |
USD 377.95 M
|
Dec. 31, 2023 | USD 7.95 | -0.62% |
|
Canada |
|
| 6 |
USD 212.08 M
|
Dec. 31, 2023 | USD 1.22 | 2.52% |
|
Canada |
|
| 7 |
USD 97.70 M
|
Dec. 31, 2023 | USD 2.96 | 1.10% |
|
Canada |
|
| 8 |
USD 80.52 M
|
Dec. 31, 2023 | USD 9.51 | -0.80% |
|
Canada |
|
| 9 |
USD 31.18 M
|
Dec. 31, 2023 | USD 6.23 | -0.19% |
|
Canada |
|
| 10 |
USD 30.32 M
|
March 31, 2024 | USD 2.65 | -1.93% |
|
Canada |
|
| 11 |
USD 9.21 M
|
June 30, 2024 | USD 3.15 | 0.64% |
|
Canada |
|
| 12 |
USD 8.04 M
|
Aug. 31, 2024 | USD 1.86 | 5.08% |
|
Canada |
|
| 13 |
USD 7.05 M
|
Sept. 30, 2023 | USD 1.91 | 1.06% |
|
Canada |
|
| 14 |
USD 4.64 M
|
Dec. 31, 2023 | USD 0.89 | -2.92% |
|
Canada |
|
| 15 |
USD -20.87 M
|
Nov. 30, 2023 | USD 1.52 | 2.02% |
|
Canada |
Frequently Asked Questions
-
Which Clinical Trials company in Canada has the highest Shareholders' Equity ?
The Clinical Trials company in Canada with the highest Shareholders' Equity is AbCellera Biologics Inc. (NasdaqGS: ABCL) at USD 1.15 B.
-
Which Clinical Trials company in Canada has the lowest Shareholders' Equity ?
The Clinical Trials company in Canada with the lowest Shareholders' Equity is Theratechnologies Inc. (Toronto Stock Exchange: TH.TO) at USD -20.87 M.
-
What are the top 10 Clinical Trials companies in Canada by Shareholders' Equity ?
The top 10 Clinical Trials companies in Canada by Shareholders' Equity are AbCellera Biologics Inc., Xenon Pharmaceuticals Inc., Knight Therapeutics Inc., Zymeworks Inc., Aurinia Pharmaceuticals Inc., Repare Therapeutics Inc., HLS Therapeutics Inc., Cipher Pharmaceuticals Inc., Profound Medical Corp. and Medexus Pharmaceuticals Inc..
-
What are the bottom 10 Clinical Trials companies in Canada by Shareholders' Equity ?
The bottom 10 Clinical Trials companies in Canada by Shareholders' Equity are Theratechnologies Inc., XORTX Therapeutics Inc., Edesa Biotech, Inc., Lexaria Bioscience Corp., InMed Pharmaceuticals Inc., Medexus Pharmaceuticals Inc., Profound Medical Corp., Cipher Pharmaceuticals Inc., HLS Therapeutics Inc. and Repare Therapeutics Inc..
